Intellego Technologies (INT) Investor Update summary

Recent financial performance and growth

• Achieved strong Q2 results with significant revenue growth, improved margins, and cash flow, ending the quarter with SEK 100 million (EUR 9 million) in the bank.

• Revenue as of end of Q2 reached EUR 40 million, with hundreds of global customers and a high proportion of recurring business.

• EBIT margin and operating cash flow have both shown notable improvement, with Q2 EBIT margin reaching 71%.

• Company maintains a lean, cost-efficient structure, prioritizing R&D and growth over fixed office costs.

• Guidance has been conservative after missing targets previously, but recent performance has consistently exceeded targets.

Market opportunity and business model

• Focuses on quality assurance tools for UV disinfection, UV curing, and horticulture, with patented technology protected until 2042.

• Disinfection market alone estimated at EUR 1.6 billion annually, with curing market expected to be even larger.

• Collaborations with major industry players like Henkel and Likang are key to growth, though scaling these partnerships takes time.

• Business model includes both product sales (color indicators, capital equipment) and digital solutions (app system for dosimeter readouts).

• Three to five-year goal is to reach EUR 200 million in revenue and EUR 60 million EBIT.

Operational strategy and risk management

• Maintains a flexible, decentralized structure to maximize cost efficiency and agility.

• Employee retention is managed through individualized incentives, including stock options and tailored compensation.

• Plans to expand teams across R&D, finance, sales, and marketing to support rapid growth.

• Uses EKN (Swedish Export Credit Agency) to insure larger export receivables, minimizing credit risk.

• Actively manages working capital and is open to using factoring to further strengthen cash flow.